In this Demystifying Medicine video from McMaster University, learn more about idiopathic pulmonary fibrosis (IPF), a scleroderma-related condition that currently has no known cause. Back in February, researchers presented a study investigating the therapeutic effect of the monoclonal antibody CM-101 in animal models of systemic sclerosis (SSc) and…
Gallery
Social Clips
Scleroderma and the GI Tract
In this video by the Scleroderma Foundation, Greater Chicago Chapter, watch Michael Brown, MD, Professor of Medicine, Rush University Medical Center, talk about scleroderma and the gastrointestinal tract (GI). Read the latest scleroderma and gastrointestinal (GI) problems news here: https://bit.ly/1ZGMEEZ…
Recent Posts
- Blood protein may help predict lung decline in scleroderma-related ILD
- Lack of small blood vessel damage patterns may predict milder SSc
- Wireless sensor may help track scleroderma skin changes at home
- New scleroderma survey seeks patient input to guide future research
- Scleroderma added to NIH project targeting autoimmune diseases
- Off-the-shelf cell therapy shows early promise as scleroderma treatment
- Trial to test scleroderma treatments at earliest stages of disease
- Off-label JAK inhibitors may stabilize lung function in systemic sclerosis
- Distinct symptom pattern found for triple-negative scleroderma patients
- Plant-based nanoparticle therapy eases skin thickening in SSc: Study